0001144204-13-041755.txt : 20130729 0001144204-13-041755.hdr.sgml : 20130729 20130729184254 ACCESSION NUMBER: 0001144204-13-041755 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130712 FILED AS OF DATE: 20130729 DATE AS OF CHANGE: 20130729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MANGANO ROSS J CENTRAL INDEX KEY: 0001013724 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 13993717 MAIL ADDRESS: STREET 1: 112 WEST FEFFERSON BOULEVARD STREET 2: SUITE 613 CITY: SOUTH BEND STATE: IN ZIP: 46634 4/A 1 v351184_4a.xml OWNERSHIP DOCUMENT X0306 4/A 2013-07-12 2013-07-16 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001013724 MANGANO ROSS J C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 0 0 0 Option to Purchase 1.06 2013-07-12 4 A 0 20000 0 A 2023-07-11 Common Stock 20000 20000 D Option vests over a four year period beginning on the first anniversary of the grant date. This Amendment is being filed solely to include Exhibit 24. /s/ Roland S. Chase, as attorney in fact 2013-07-29 EX-24 2 v351184_ex24.htm EXHIBIT 24

CONFIRMING STATEMENT

Know all by these presents, that the undersigned hereby constitutes and appoints each of Arthur S. Przybyl, Charlotte C. Arnold, Paul A. Gajer, Jane A. Meyer and Roland S. Chase (the “Authorized Signatories”), or any one or more of them, the undersigned’s true and lawful attorneys-in-fact to:

(1)

prepare and execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer or director of BioSante Pharmaceuticals, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder, and any other forms or reports the undersigned may be required to file with the U.S. Securities and Exchange Commission in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, or Form 3, 4, or 5, or other form or report, and timely file such form or report with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of July, 2013.


		/s/ Ross J. Mangano

		Name: Ross J. Mangano